论文部分内容阅读
目的:观察腹腔镜肾癌根治术治疗肾癌的疗效。方法:选取2013年12月~2015年12月于我院诊治的肾细胞癌并行肾癌根治术患者70例,其中42例患者行腹腔镜肾癌根治术,纳入微创组;28例患者行开放性肾癌根治术,纳入对照组。比较两组患者围手术期情况、术后第3天炎症指标与肾功能、围术期并发症。结果:与对照组相比,微创组患者手术时间、住院时间、手术切口较短,术后下床走动时间、术后停止禁食时间较早,手术出血量、手术费用较少(P<0.001)。与对照组相比,微创组患者WBC、CRP水平较低(P<0.001)。微创组患者围术期总并发症发生率为4.8%,低于对照组(21.5%),差异有统计学意义(x~2=4.610,P=0.032)。结论:腹腔镜肾癌根治术治疗肾癌较开放性肾癌根治术有疗效佳、安全性好、术后恢复快及并发症少的优势,值得临床推广。
Objective: To observe the effect of laparoscopic radical nephrectomy on renal cell carcinoma. Methods: Seventy patients with renal cell carcinoma underwent radical nephrectomy in our hospital from December 2013 to December 2015 were selected. Among them, 42 patients underwent laparoscopic radical nephrectomy and were included in the minimally invasive group; 28 patients underwent radical nephrectomy Open radical nephrectomy, included in the control group. Perioperative conditions, postoperative inflammation indicators and renal function, perioperative complications were compared between the two groups. Results: Compared with the control group, the minimally invasive group had shorter operation time, shorter hospital stay, shorter operative time, longer time to move out of bed, shorter fasted time after operation, less operative bleeding and less operation costs (P < 0.001). Compared with the control group, patients with minimally invasive WBC, CRP levels were lower (P <0.001). The minimally invasive group had a perioperative total complication rate of 4.8%, which was lower than that of the control group (21.5%). The difference was statistically significant (x 2 = 4.610, P = 0.032). Conclusions: Laparoscopic radical nephrectomy is superior to open radical nephrectomy in the treatment of renal cell carcinoma, which is safe, safe and quick in postoperative recovery with less complications. It is worthy of clinical promotion.